tiprankstipranks
Trending News
More News >
Grace Therapeutics (GRCE)
NASDAQ:GRCE
US Market

Grace Therapeutics (GRCE) Income Statement

Compare
1,159 Followers

Grace Therapeutics Income Statement

Last quarter (Q3 2024), Grace Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Grace Therapeutics's net income was $-4.16M. See Grace Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 196.00K$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 120.00K$ 0.00
Operating Expenses
$ 12.85M$ 52.16M$ 15.59M$ 16.54M$ 24.44M
Depreciation and Amortization
$ 11.00K$ 124.00K$ 0.00$ 924.00K$ 2.32M
EBITDA
$ -11.33M$ -18.12M$ -15.34M$ -9.79M$ -22.95M
Operating Income
$ -12.85M$ -52.16M$ -15.59M$ -16.42M$ -24.44M
Other Income/Expenses
$ -1.83M$ 184.00K$ 5.12M$ -3.26M$ -1.07M
Pretax Income
$ -14.69M$ -51.97M$ -10.47M$ -19.68M$ -25.51M
Net Income
$ -12.85M$ -42.43M$ -9.82M$ -19.68M$ -25.51M
Per Share Metrics
Basic EPS
$ -1.73$ -5.71$ -1.62$ -7.98$ -14.40
Diluted EPS
$ -1.73$ -5.71$ -1.62$ -7.98$ -14.40
Weighted Average Shares Outstanding
7.44M 7.44M 6.14M 2.47M 1.76M
Weighted Average Shares Outstanding (Diluted)
7.44M 7.44M 6.14M 2.47M 1.76M
Currency in USD

Grace Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis